Newsroom

Industry News

5 Mar

Lightlake Therapeutics Inc., Licensor Of A Treatment To Reverse Opioid Overdoses, To Webcast Live, At VirtualInvestorConferences.com March 5th

Lightlake invites individual and institutional investors to attend interactive real-time presentation on Lightlake’s progress with its opioid overdose reversal treatment and achievements in other areas. NEW YORK , Feb. 27, 2015 /PRNewswire/ — Lightlake Therapeutics Inc. (“Lightlake”) (LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid...

Read more

5 Mar

Amedica Corporation Reports Fourth Quarter and Full Year 2014 Financial Results

Full Year Silicon Nitride Ceramic Revenue Increases 41% Year-Over-Year Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the fourth quarter and full year ended December 31, 2014. “This past year has been remarkable for Amedica and...

Read more

5 Mar

Inovio Pharmaceuticals Welcomes Nancy Wysenski to Its Board of Directors

Inovio Pharmaceuticals, Inc. (INO), a leader in the development of immunotherapies for cancer and infectious diseases, announced today that Nancy Wysenski joined its Board of Directors. Ms. Wysenski, a commercial pharmaceutical executive, has over 30 years’ experience in the pharmaceutical industry and has launched numerous new products. Ms. Wysenski...

Read more

5 Mar

Eco-Shift Power Corp. (OTCBB: ECOP) and Sun Industries Announce Extension of Contract With Fortune 500 Big Box Retailer for Upgrading to LED Lighting

Eco-Shift Power (OTCBB: ECOP), one of Canada’s leading energy management and lighting firms, together with their wholly-owned subsidiary, Sun and Sun Industries Inc. (“Sun Industries”) announce the extension of a contract with a Fortune 500 National Retailer undergoing a sustainable shift to highly efficient LED technologies. Sun Industries announced...

Read more

5 Mar

Soligenix to Present at the 27th Annual ROTH Conference

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will give a corporate presentation at...

Read more

4 Mar

U.S. Precious Metals, Inc. (USPR) Announces 2015 Drilling Program

U.S. Precious Metals, Inc. (USPR) announces the hiring of ACT HOLDINGS, LLC, (ACT) to act as operator for the Company’s 2015 core drilling program on its mining concessions located in Michoacan, Mexico. The program initially consists of 5,000 meters that target areas near drill holes from prior drilling campaigns...

Read more

Page 1 of 5212345...102030...Last »

Latest Tweets